Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021

Emerg Infect Dis. 2021 Sep 27;27(11). doi: 10.3201/eid2711.211886. Online ahead of print.ABSTRACTIn Israel, the BNT162b2 vaccine against severe acute respiratory syndrome coronavirus 2 was approved for use in adolescents in June 2021, shortly before an outbreak of B.1.617.2 (Delta) variant-dominant infection. We evaluated short-term vaccine effectiveness and found the vaccine to be highly effective among this population in this setting.PMID:34570694 | DOI:10.3201/eid2711.211886

Source: Emerging Infectious Diseases - September 27, 2021 Category: Infectious Diseases Authors: Aharona Glatman-Freedman Yael Hershkovitz Zalman Kaufman Rita Dichtiar Lital Keinan-Boker Michal Bromberg Source Type: research